Search Results - "Macfarlane, PW"

A comparison of commonly used QT correction formulae: The effect of heart rate on the QTc of normal ECGs by Luo, Shen, Michler, Kurt, Johnston, Paul, Macfarlane, Peter W.

“…The corrected QT interval (QTc) is widely used in pharmaceutical studies and clinical practice. Bazett’s QT correction formula is still the most popular,…”
Get full text

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study by Sattar, Naveed, Gaw, Allan, Scherbakova, Olga, Ford, Ian, O'Reilly, Denis St J, Haffner, Steven M, Isles, Chris, Macfarlane, Peter W, Packard, Chris J, Cobbe, Stuart M, Shepherd, James

“…The National Cholesterol Education Program (NCEP) recently proposed a simple definition for metabolic syndrome. Information on the prospective association of…”
Get full text

Practice standards for electrocardiographic monitoring in hospital settings : An American heart association scientific statement from the councils on cardiovascular nursing, clinical cardiology, and cardiovascular disease in the young by DREW, Barbara J, CALIFF, Robert M, FUNK, Marjorie, KAUFMAN, Elizabeth S, KRUCOFF, Mitchell W, LAKS, Michael M, MACFARLANE, Peter W, SOMMARGREN, Claire, SWIRYN, Steven, VAN HARE, George F

Get full text

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial by Shepherd, James, Blauw, Gerard J, Murphy, Michael B, Bollen, Edward LEM, Buckley, Brendan M, Cobbe, Stuart M, Ford, Ian, Gaw, Allan, Hyland, Michael, Jukema, J Wouter, Kamper, Adriaan M, Macfarlane, Peter W, Meinders, A Edo, Norrie, John, Packard, Chris J, Perry, Ivan J, Stott, David J, Sweeney, Brian J, Twomey, Gillian, Westendorp, Rudi GJ

“…Although statins reduce coronary and cerebrovascular morbidity and mortality in middle-aged individuals, their efficacy and safety in elderly people is not…”
Get full text

Elevated Alanine Aminotransferase Predicts New-Onset Type 2 Diabetes Independently of Classical Risk Factors, Metabolic Syndrome, and C-Reactive Protein in the West of Scotland Coronary Prevention Study by SATTAR, Naveed, SCHERBAKOVA, Olga, FORD, Ian, O'REILLY, Denis St. J, STANLEY, Adrian, FORREST, Ewan, MACFARLANE, Peter W, PACKARD, Chris J, COBBE, Stuart M, SHEPHERD, James

“…Elevated Alanine Aminotransferase Predicts New-Onset Type 2 Diabetes Independently of Classical Risk Factors, Metabolic Syndrome, and C-Reactive Protein in the…”
Get full text

Pravastatin and the development of diabetes mellitus : Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study by FREEMAN, Dilys J, NORRIE, John, PACKARD, Christopher J, SHEPHERD, James, GAW, Allan, SATTAR, Naveed, NEELY, R. Dermot G, COBBE, Stuart M, FORD, Ian, ISLES, Christopher, LORIMER, A. Ross, MACFARLANE, Peter W, MCKILLOP, James H

“…We examined the development of new diabetes mellitus in men aged 45 to 64 years during the West of Scotland Coronary Prevention Study. Our definition of…”
Get full text

Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS) by West of Scotland Coronary Prevention Study Group

“…The West of Scotland Coronary Prevention Study was a primary prevention trial that demonstrated the effectiveness of pravastatin (40 mg/d) in reducing…”
Get full text

Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial by Cleland, JGF, Pennell, DJ, Ray, SG, Coats, AJ, Macfarlane, PW, Murray, GD, Mule, J Dalle, Vered, Z, Lahiri, A

“…The improvement in left-ventricular ejection fraction (LVEF) in response to β blockers is heterogeneous in patients with heart failure due to ischaemic heart…”
Get full text

Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease by Stott, David J, MacIntosh, Graham, Lowe, Gordon DO, Rumley, Ann, McMahon, Alex D, Langhorne, Peter, Tait, R Campbell, O'Reilly, Denis St J, Spilg, Edward G, MacDonald, Jonathan B, MacFarlane, Peter W, Westendorp, Rudi GJ

“…BACKGROUND: Homocysteine is an independent risk factor for vascular disease and is associated with dementia in older people. Potential mechanisms include…”
Get full text

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia by Shepherd, James, Cobbe, Stuart M, Ford, Ian, Isles, Christopher G, Lorimer, A. Ross, Macfarlane, Peter W, McKillop, James H, Packard, Christopher J

“…Earlier trials of lipid-lowering drugs in the primary prevention of coronary heart disease have demonstrated that lowering cholesterol levels in middle-aged…”
Get full text

Association between high-density lipoprotein and cognitive impairment in the oldest old by Van Exel, Eric, de Craen, Anton J. M., Gussekloo, Jacobijn, Houx, Peter, Bootsma-van der Wiel, Annetje, Macfarlane, Peter W., Blauw, Gerard J., Westendorp, Rudi G. J.

“…Low high‐density lipoprotein cholesterol is associated with an increased risk for cardiovascular disease and stroke. At the same time, cardiovascular disease…”
Get full text

Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the prospective study of pravastatin in the elderly at risk (PROSPER) by PACKARD, Chris J, FORD, Ian, HYLAND, Michael, JUKEMA, J. Wouter, KAMPER, Adriaan M, MACFARLANE, Peter W, PERRY, Ivan J, STOTT, David J, SWEENEY, Brian J, TWOMEY, Cillian, WESTENDORP, Rudi G. J, ROBERTSON, Michele, SHEPHERD, James, BLAUW, Gerard J, MURPHY, Michael B, BOLLEN, Edward L. E. M, BUCKLEY, Brendan M, COBBE, Stuart M, GAW, Allan

“…Statins are important in vascular disease prevention in the elderly. However, the best method of selecting older patients for treatment is uncertain. We…”
Get full text

The design of a prospective study of pravastatin in the elderly at risk (PROSPER) by Shepherd, James, Blauw, Gerard Jan, Murphy, Michael B, Cobbe, Stuart M, Bollen, Edward L.E.M, Buckley, Brendan M, Ford, Ian, Jukema, J.Wouter, Hyland, Michael, Gaw, Allan, Lagaay, A.Margot, Perry, Ivan J, Macfarlane, Peter W, Meinders, A.Edo, Sweeney, Brian J, Packard, Chris J, Westendorp, Rudi G.J, Twomey, Cillian, Stott, David J

“…The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) is a randomized, double-blind, placebo-controlled trial designed to test the hypothesis…”
Get full text

Testing cognitive function in elderly populations: the PROSPER study by Houx, P J, Shepherd, J, Blauw, G-J, Murphy, M B, Ford, I, Bollen, E L, Buckley, B, Stott, D J, Jukema, W, Hyland, M, Gaw, A, Norrie, J, Kamper, A M, Perry, I J, MacFarlane, P W, Meinders, A Edo, Sweeney, B J, Packard, C J, Twomey, C, Cobbe, S M, Westendorp, R G

“…Objectives: For large scale follow up studies with non-demented patients in which cognition is an endpoint, there is a need for short, inexpensive, sensitive,…”
Get full text

Can cardiac vagal tone be estimated from the 10-second ECG? by Hamilton, Ruth M, Mckechnie, Peter S, Macfarlane, Peter W

“…Background: Heart rate variability (HRV) recorded over 5 min or 24 h is used increasingly to measure autonomic function and as a prognostic indicator in…”
Get full text

The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of Coronary heart disease by LEDMYR, Helena, MCMAHON, Alex D, EHRENBORG, Ewa, NIELSEN, Lars B, NEVILLE, Matt, LITHELL, Hans, MACFARLANE, Peter W, PACKARD, Christopher J, KARPE, Fredrik

“…The microsomal triglyceride transfer protein (MTP) transfers lipids into apolipoprotein B-containing lipoproteins for secretion from liver, intestine, and…”
Get full text

Age, sex, and the ST amplitude in health and disease by Macfarlane, Peter W.

“…Electrocardiograms (ECGs) from 1,338 apparently healthy adults were analyzed to calculate limits of normality of a variety of ECG measurements. A second set of…”
Get full text

Influence of lead selection and population on automated measurement of QT dispersion by MACFARLANE, P. W, MCLAUGHLIN, S. C, RODGER, J. C

“…The study of QT dispersion (QTd) is of increasing clinical interest, but there are very few data in large healthy populations. Furthermore, there is still…”
Get full text

Interaction of atherosclerosis and inflammation in elderly subjects with poor cognitive function by VAN EXEL, E, DE CRAEN, A. J. M, REMARQUE, E. J, GUSSEKLOO, J, HOUX, P, WIEL, A. Bootsma-Van, FRÖLICH, M, MACFARLANE, P. W, BLAUW, G. J, WESTENDORP, R. G. J

“…To test the hypothesis that a pro-inflammatory response is associated with cognitive impairment among individuals with cardiovascular disease. All 85-year-old…”
Get full text

Integration of Genetics into a Systems Model of Electrocardiographic Traits Using HumanCVD BeadChip by Gaunt, Tom R, Shah, Sonia, Nelson, Christopher P, Drenos, Fotios, Braund, Peter S, Adeniran, Ismail, Folkersen, Lasse, Lawlor, Debbie A, Casas, Juan-Pablo, Amuzu, Antoinette, Kivimaki, Mika, Whittaker, John, Eriksson, Per, Zhang, Henggui, Hancox, Jules C, Tomaszewski, Maciej, Burton, Paul R, Tobin, Martin D, Humphries, Steve E, Talmud, Philippa J, Macfarlane, Peter W, Hingorani, Aroon D, Samani, Nilesh J, Kumari, Meena, Day, Ian N.M

“…BACKGROUND—Electrocardiographic traits are important, substantially heritable determinants of risk of arrhythmias and sudden cardiac death. METHODS AND…”
Get full text